Federated learning for lesion segmentation in multiple sclerosis: a real-world multi-center feasibility study
Sarah Hindawi1, Bartlomiej Szubstarski2, Eric Boernert3
1Hoffmann-La Roche Limited, Mississauga, ON, Canada.
Frontiers in Neurology
|September 26, 2025
Summary
Federated learning (FL) enabled secure, collaborative AI for multiple sclerosis (MS) lesion segmentation across multiple hospitals without sharing patient data. This approach shows promise for advancing automated neuroimaging analysis while adhering to privacy regulations.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Multiple sclerosis (MS) is a chronic, disabling neuroinflammatory disease.
- Accurate segmentation of MS lesions on MRI is vital for disease monitoring and treatment evaluation.
- Manual segmentation is labor-intensive and variable; automated methods require large, diverse datasets, posing privacy and data-sharing challenges.
Purpose of the Study:
- To apply and evaluate Federated Learning (FL) for automated multiple sclerosis (MS) lesion segmentation in a real-world clinical setting.
- To assess the feasibility of using FL to train AI models on distributed datasets without compromising patient privacy.
Main Methods:
- Utilized the self-configuring nnU-Net model within a Federated Learning framework.
- Trained the model on 512 MRI cases from three different clinical sites without direct data sharing.
- Assessed model performance using Dice scores on held-out test sets.
Main Results:
- The federated model achieved Dice scores between 0.66 and 0.80 across test sets.
- Performance varied across sites, indicating the impact of data heterogeneity.
- Demonstrated the potential of FL for scalable and secure AI in distributed neuroimaging.
Conclusions:
- Federated Learning offers a viable, privacy-preserving method for developing robust AI tools for MS lesion segmentation.
- This approach facilitates collaborative AI development in neuroimaging, addressing data privacy and regulatory concerns.
- Supports the adoption of secure, collaborative AI for medical research and clinical applications.


